. Release Date: 27/06/22 09:19; Summary: SPL signs expanded DEP research agreement with US Biopharma; Price Sensitive: Yes; Download Document 194. 48. The usual suspects on Hotcopper were pumping the Hong Kong and Macau ’deal’ last year as a game changer and rivers of gold were going to flow across the border from China for Viraleze, apparently. 0¢. PEG-b-pHPMA-lactate: Docetaxel, microtubule inhibitor/hydrolytic linkerwaste of cash by the time spl manage to do anything with nasal spray covid will have a vaccine if there is one thing spl have deomstrated it is an inability to do anything in a timely fashion. Last updated 15. Each to their own. You should withdraw the statement. New Zealand Dollar. Views. ASX - By Stock. 37 Sentiment: Buy Disclosure: Held. ASX - By Stock. 56% 14. The recent announcement about Viraleze nasal spray going into production in Jan 2021, trying to hit the Euro markets in q1-q2 2021, caused a stir in the SP. Gumnut, first class summary and analysis! In the end, basic fundamentals will rule the day re the success or otherwise of SPL - our orphaned dendrimer technology company. ASX - Day Trading. I recall reading your postings (largely optimistic, I think) about SPL when I first stumbled onto this site years ago. AZ will be watching Phase 2 results and assessing the market against the potential SPL bill. 15667. Stay informed on the day’s latest market trends and receive exclusive access to HotCopper’s trending analysis with inside stories from TMH to help you make sense of what’s happened and navigate what’s ahead. ASX - By Stock. With SPL we have entered a relatively short term period where things are going to develop into something serious. Your post is very vague in its relationship somehow with spl, but the intent of the constant negative narrative is obvious. 0¢ STARPHARMA HOLDINGS LIMITED - Discussion. ASX - General. It’s unlikely to happen, but personally I hope Rob Thomas and Jackie Fairley fall on their sword prior to the AGM. Eight (8) contributors to the HC SPL thread made price predictions (thank. More. The Vancouver Island Wave program is the Island’s highest level of youth soccer participating in the BC Soccer Premier League. Starpharma AGM Summary (Part 1) Oh. Canadian Dollar. 1. Interesting write-up. I should declare that I am. 5. 83453. Application for quotation of securities - SPL. 2:00 am Eastern Standard Time Australia. Search for Betafem BV, Fleurstat or Viraleze and you will often get competing products but no reference to what you searched for (that is the way Google works). 45K. ASX - General. . Join the. It is now more than ever that SPL needs to communicate with the market and keep everyone informed of any updates, because the radio silence and smoke and mirrors approach is evidently NOT WORKING. 0¢. ASX - By Stock. 1 Introduction. And somebody must be buying all the shares that are being sold. ASX - Day TradingCurrent SPL CEO setting a pretty high bar here, especially in light of the less than sparkling track record. Some days I wondered if I'd see 91c again, but when the Vivagel phase 3 announcement came out I loaded up big time. Forums. ASX - Day TradingThe short position has been negligible in Starpharma since we go booted from the ASX300 and the shorts were able to cover a large portion of their position at rock bottom share prices in the re-balance. and even when Big pharma are challenged legally and lose in court as in Johnson and Johnson bladder slings - its 20 years after the tort, 8 yrs fighting in court to then be waiting waiting waiting for compensation not for pain and suffering in VICTORIA just inconvenience costs such as buying pads and pain killers. Hi folks SPL seems to have gone through a major change in the last 5 months (obviously because of recent news in that period) . , page-2. I recall reading your postings (largely optimistic, I think) about SPL when I first stumbled onto this site years ago. Share Given the current status of Starpharma, I am surprised any of these made it through from 2020 but it appears 121,082 did. . . 0¢. Last updated 15. . Please type the title in sentence case (that is lowercase with only the first letter or the first word in capitals) and without any punctuation. . 8%. Check out the spin on this promo---One ASX company Set to Revolutionise the $112 BILLION Cancer-Drug MarketBy: Adam SurpliceIndustry experts expect that. Application for quotation of securities - SPL. And SPL still cannot generate enough revenue to even break even! Expand While the current management may be very astute at carrying out research and developing potentially great drug/drug platforms, they ARE NOT showing any signs of success when it comes to commercialisation of these products . Its time SPL got down and dirty and prepare their WAR plan in anticipation of the trial being successful. CEO knows it is all going. )” ~@antibotter Jan 2019 (Hotcopper post #37005569) After ASX announcement ‘Positive DEP phase 2 interim results in prostate cancer’: SPL are obliged to make announcements and unfortunately they have not included enough detail so shareholders are aware of timings and actual release in Indonesia nor real scale. Eight (8) contributors to the HC SPL thread made price predictions (thank. 00%. Is the board simply resting on their collective (pre spl) laurels?Just in case you missed it HEALTHCARE Starpharma (SPL) Strong results from first in man Phase 1 DEP Docetaxel trial validate SPL’s DEP platform Safety. Last updated 14. It is lengthy but well worth the time. Quarterly Activities Report & Appendix 4CLooking further into the AGM notice, Resolution 3 is a massive slap in the face to share holders!!!Basically the company is proposing to dish out a bonus. ASX - Day Trading. 70 Sentiment: Sell Disclosure: Held Not only did AZ not announce completion of Phase 1 with stellar results, the commencement of Phase 2 and a big milestone payment to SPL as the pompom brigade were postulating, it was just interim Phase 1 results and dose escalation apparently continues. Join the HotCopper ASX Stock discussion forum for STARPHARMA HOLDINGS LIMITED. And SPL still cannot generate enough revenue to even break even! Expand While the current management may be very astute at carrying out research and developing potentially great drug/drug platforms, they ARE NOT showing any signs of success when it comes to commercialisation of these products . I am closely watching the state of the World Economy, particularly China and the U. Ineffective deals and sloppy clinical trials and regulatory tactics might be able to be gloss over for years but over times it show in the bottom line. Then you have the obvious issues with distribution with Lloydsand possiblly really cheap deal with Vietnam let alone teh mysterious India ,. To make matters worse he has AZD0466 on hold through no fault of the dendrimer technology, which appears to be highly successful in dealing with the drugs toxicity. But SPL is different, isn't it? SPL is not a penny dreadful (not yet anyway) and it is not a resources company and it has enough funds to last a few more years even if it never makes a cent. IMO they haven't . The results will be good but will they be good enough for SPL to be able to do the deals. On the subject of upfront licence fees Bell Potter in one of their analyses on SPL several years ago gave estimates of the likely upfront fees at $15M for Dep Doc, $8M for Dep Cab & $30M for Dep Irin. Overview. Market Cap $55. Why am am I still positive well let's go through my path to here in 2016/17/18 I was buying shares I bought one package of 100,000 for 66 cents and ended. Share It's confusing isn't it So what we have in pre-clinical trials Dep Docetaxel has been used in combination with Gemcitabine Dep Cabazitaxel has been used in combination with GemcitabineReading the TGA decision to fine Starpharma re Viraleze in 2021, and the requirement that SPL apply for approval of Viraleze as Medicine not Medical Device which has been the approval category in many other jurisdictions, I understand from questions I asked at the November 2022 AGM that SPL paid the fine and were concerned that there. . ASX - General. ASX - Short Term Trading. Advertise on HotCopper. ASX - Day TradingDoes Spl deserve to be seven times less in mkt cap to another biotech that has one phase 2 product spl potentially 3 and commercialisation deal with astra zeneca and collaboration deals with Merck and Genentech. HotCopper has news, discussion, prices and market data on SPLITIT PAYMENTS LTD. And SPL still cannot generate enough revenue to even break even! Expand While the current management may be very astute at carrying out research and developing potentially great drug/drug platforms, they ARE NOT showing any signs of success when it comes to commercialisation of these products . Gumnut, first class summary and analysis! In the end, basic fundamentals will rule the day re the success or otherwise of SPL - our orphaned dendrimer technology company. $0. 5¢. Starpharma (SPL) Shares in the nano-biotechnology group bucked the falls in the wider market on Monday after it announced a deal with a division of US pharmaceutical giant Ely Lilly to extend the application of its technologies in the animal health area. Join the HotCopper ASX share market forum today for free. 0¢. 70 Sentiment: Sell Disclosure: HeldNot only did AZ not announce completion of Phase 1 with stellar results, the commencement of Phase 2 and a big milestone payment to SPL as the pompom brigade were postulating, it was just interim Phase 1 results and. Share Interesting and positive early pre-clinical results. No China virus, no Flu, no colds. SPL. On the subject of upfront licence fees Bell Potter in one of their analyses on SPL several years ago gave estimates of the likely upfront fees at $15M for Dep Doc, $8M for Dep Cab & $30M for Dep Irin. *talks with BIG multinational Company, should've already taken place with deals completed and signed soon after the trial. Gumnut, first class summary and analysis! In the end, basic fundamentals will rule the day re the success or otherwise of SPL - our orphaned dendrimer technology company. Created with Sketch. ASX - Day TradingTime to top up again for me What about youBetween Oct 2017 and Mar 2018 it seemed like we held pretty consistently above $1. 00%. More. 0. 22/9/2000 CSL $11. 6% downward extention down to (0. $0. 8. Forums. Last updated 15. Share It is now 2 years and 8 months since CEO Jackie Fairley bought any shares in her own company on-market. SUBMISSION STEPS. 5¢. An expat Indonesian friend did have search for me but didn't find any promotion etc a little while ago. . Is this a case of short memories? The best one can say is her surprise is disingenuous. . I remember seeing a post on SPL had 41000 views. That won’t be a shock to. 0834. 3. Market Cap $57. HotCopper is Australia's largest free and independent stock market trading forum for ASX investors to discuss share prices, the stock market and more. Working in a. Sorry a Faulty Towers and BMC tragic and possibly a SPL one as well . SPL Price at posting: 49. 06B ! Add to my watchlist. Market . Even Pfizer won’t comment on him. 63M. It totally unrealistic that Merck will enter the clinic in 4-5 months. TSASC INC N Y 5% 0. Market . SPL Price at posting: 14. A sad state of affairs IMO. 1dB. 57% 13. Forums. . 0¢ Sentiment: Hold Disclosure: Held Share Hi Folks Time to revisit the SPL Weekly chart. Become a member of Australia's largest investment discussion forum. Forums. And somebody must be buying all the shares that are being sold. Target our investor community with our. Both were very well paid and, if the "forward looking statements" are to be believed would have had the box seat in a company with a great future. And SPL still cannot generate enough revenue to even break even! Expand While the current management may be very astute at carrying out research and developing potentially great drug/drug platforms, they ARE NOT showing any signs of success when it comes to commercialisation of these products . DISCOVER THE BATTERY METALS REVOLUTION. Market . Come on SPL, complete these trials for the Companys sake, the shareholders sake and all the people out there suffering from these cancers. Join the HotCopper ASX share market forum today for free. Attached link highlights some of the complexities involved more broadly. While the chart is not good there is a glimmer hope maybe emerging. 0000. In March 2020 the SPL share price dropped to a low of 0. Join the HotCopper ASX share market forum today for free. Created with Sketch. 47pm 20/11/2023 ? HotCopper has news, discussion, prices and market data on NOVONIX LIMITED. Perhaps they will today tomorrow. (OTCQX: SPHRY | ASX: SPL) Thursday, June 25, 2020 12:00 p. ASX - By Stock. Market Cap $77. m. Last updated 15. 36. I was astounded to see that you Jackie were rewarded with a$200,000 bonus during this time. Gumnut, first class summary and analysis! In the end, basic fundamentals will rule the day re the success or otherwise of SPL - our orphaned dendrimer technology company. LEADING THE BATTERY METALS REVOLUTION. 37. Share lol @col69 the phrase "in parallel we are continuing discussions with potential commercial partners" is now etched into SPL's manual for any asx announcements or releases to the public. Last updated 15. ASX - By Stock. Created with Sketch. . Interesting write-up. Market Dep Cabazitaxel will be licenced out before initiation of Phase 2 clinical trial (in other words this year. 30. Created with Sketch. Or primary care stop like a medical centre or clinic- stating the obvious- hope SPL have better marketers than I) Also would like to see what the USA have done to allow retail investor to get involved in per IPO rather than just institutions investors getting the huge discount to Share Price. ASX - By Stock. We, as investors in this company deserve to knowmore. 04KBIMO there’s money to be made trading SPL but I do not believe in holding, hoping, trusting and loving SPL at all. Charts. 0¢ Sentiment: None Disclosure: Not HeldHi FolksIts a boring market today and I had time to revisit SPL, where I am a long, long time weary holder. 0 Great. Good luck to all. 5¢ STARPHARMA HOLDINGS LIMITED - Discussion. If SPL come out with more data and partners or a potential pathway to sales, great, i will change my view and the price will likely spike. ASX - Day Trading Last day Spl remains in ASX300 Institutions and/or shorters buying TIME LINE At auction today there were 20 million shares wanted to buy and 11 millions shares wanted to sell Notice after close of auction there were still 10 million shares wanted to buy and 450k to sell Merck has tightened its ties to Starpharma as it continues to build out its antibody-drug conjugate (ADC) capabilities, signing a second agreement that will enable it to evaluate candidates based. Anyways, after nearly 20 years in SPL, I have broken every investment rule and plunged in last week to top up and reduce my average entry cost. SPL conducts a "trial" (use that word loosely) in of all places WA !! Yet our commercial hotshots cannot arrange a deal with a WA based company who appear highly capable and connected in getting distribution to sought after sectors like "Allied Health practitioners, the corporate sector and government". 28pm 13/11/2023 ? TMG (ASX) Chart. Share I sometimes wonder if they actually work at Starpharma. Created with Sketch. m. HotCopper has news, discussion, prices and market data on SPLITIT PAYMENTS LTD. Created with Sketch. Join the HotCopper ASX share market forum today for free. Today it closes up 5% on the high of the bar and all we here. It knows of Viraleze - so its rationale for letting Viraleze meander through regulatory processes with no due haste or intervention is mystifying. Last edited by sarge17: 28/11/22. That's how markets work sometimes. ASX - By Stock. Application for quotation of securities - SPL. We would like to show you a description here but the site won’t allow us. Click for more information. 5¢ Sentiment: Hold Disclosure: HeldThat's so funny col69 Antibotter post had you scrambling to find the link where he got that information then you copy paste the link and infer you knew already, if you did know you would for sure have posted this morning, some posters knew you were not one of them imo, still should have been an announcement let's hope results once collated. HotCopper has news, discussion, prices and market data on PROTEOMICS INTERNATIONAL LABORATORIES LTD. I think with SPL we are up to series 10 episode 100!!!! and I do laugh a lot mostly at posters naiviety On your part pretty poor form comparing such a classic comedy with such a tragic live comedy watched on the market everyday !!Anyways, after nearly 20 years in SPL, I have broken every investment rule and plunged in last week to top up and reduce my average entry cost. Target our investor community with our. 0. This extract caught my eye"The AstraZeneca programs involves $US124 million of milestones, about half of which are “relatively near”. Created with Sketch. ASX - Day TradingIn my opinion, most rational people would have to concede/agree that Starpharma’s three SPL7013 commercialised products (Fleurstat, condoms and Viraleze) have been commercial flops so far. If only SPL management would undertake Human Trials for Viraleze ? The experts are leaning towards more nasal spray use including as vaccines but our management are too busy organising their free shares. Advertise on HotCopper. Forums. Created with Sketch. Share Great ad I think it will boom in Hong Kong under the Banitore Manning name, despite what the naysayers say Banitore have a big presence in China their manufacturing of health products is also in China I would imagine they have significant pull in China and other regions, In my opinion Viraleze is set to be a huge world product in tome. 129294. Created with Sketch. ACCELERATE RESOURCES LIMITED. Last updated 14. FORTESCUE METALS GROUP LTD. Comments. It is because SPL has abrogated the marketing role to its distributors. The thread is titled so that it can be found and general enough so as to. Latest Posts. . As to finding the bottom, a milestone of sorts was reached today for SPHRY (the ADR on the US market equivalent to 10 SPL shares). Charts. 76. ASX - Day TradingGood to see another Aussie biotech who has been in communication with the FDA over the last 2 years since receiving a CRL have had their BLA resubmission accepted by the FDA. Canadian Dollar. SPL. SPL have put a lot of time and energy into Docetaxel and Cabazitaxel over many years but it is Irinotecan that seems to be wining the race, probably benefiting from the accrued knowledge from the Doc and Cab trials. Forex. ASX - By Stock. Pre-clinical results from a DEP HER2-Lutetium breast cancer model (see link below) were released by SPL in March 2021 with no update or published advancement since this announcement, and no deal/licence forthcoming. SPL Price at posting: 44. A new DFS upgrade has expanded operation capacity on-site the project from 15 gigawatt hour’s worth of battery production to 120GWh. 0¢. ASX - Day Trading. All along, SPL have said that they may sell off this entire arm of the business, or in fact once the Dep oncology advances further, perhsps split SPL into different businesses on the asx or to be sold off as completely separate businesses. Created with Sketch. $1. * All the touted pending/expected deals with the Majors come to very little with the usual statement "in discussions"Created with Sketch. There were 17,468,532 shares dumped on Monday 18/10 and as per M & G notice today only 4,359,271 shares were from M & G on Monday. Enter the title of your abstract. DJPIN. Yes I am sure @sarge17 some will come on here today that have been predicting a $2 share price for more than 6 months because it has finally hit that target today saying “I toldNotification of cessation of securities - SPL. Created with Sketch. ASX - By Stock. Advertise on HotCopper. LEADING THE BATTERY METALS REVOLUTION. StarPharma Holdings Ltd. I just hope that Starpharma shareholders sit up and notice at how the leaders of our company (the Chairman and CEO). Talk with one of our capital. 70% 14. Hey, "smart", I concur with your message. . . . 6¢. Still waiting for you @antibotter to explain why it appears you tried to influence newbies and less experienced investors into thinking that something big was imminent based on a comment in the SPL newsletter. Created with Sketch. ASX - Short Term Trading. Hey, "smart", I concur with your message. And SPL still cannot generate enough revenue to even break even! Expand While the current management may be very astute at carrying out research and developing potentially great drug/drug platforms, they ARE NOT showing any signs of success when it comes to commercialisation of these products . Provide some keywords to assist in categorisation of your abstract. ASX - Day TradingCreated with Sketch. ASX - By Stock. Again the trial results will be good but will they be sufficiently good to entice a Major into a deal. If they have poster data now it shoud be released to shareholders especially since they have used qualifying words such as good etc etc . . . 3¢. Announcement on LinkedIn today from Prof David Owen that has left SPL after 15years as VP. Commodities. granted mgt haven’t covered themselves in glory as yet but the selldown has been nothing short of astonishing. Anyways, after nearly 20 years in SPL, I have broken every investment rule and plunged in last week to top up and reduce my average entry cost. Comments. Although with SPL's track record an exceptionally good news announcement seems unlikely, it is within the realms of possibility - and this seems to be what makes SPL worth a gamble. . Join Australia’s largest community of ASX investors and share market enthusiasts in our free and independent stock market forum. Last updated 10. Some have been mentioned on this thread previously. ASX - By Stock. 75. Volume. . Gumnut, first class summary and analysis! In the end, basic fundamentals will rule the day re the success or otherwise of SPL - our orphaned dendrimer technology company. Created with Sketch. 17112. The thread is titled so that it can be found and general enough so as to. Volume. ASX - By Stock. But I’ve been having a. I constantly question why I continue to subject myself to the ongoing. We have oft heard the CEO brag about the $1B+ value of the AZD0466 milestones and license revenues. Latest Posts. 12. Looking at the short term, SPL's SP is currently perched above a technical support line at 50 cents. 0¢. ASX - General. Altech Batteries (ASX:ATC) has confirmed its Silumina Anodes project can be eight times larger than previously thought. Its a boring market today and I had time to revisit SPL, where I am a long, long time weary holder. 22%) 3,361,416 was the lowest point of total short sales for some years as of 15/06/23 (0. 199920. He doesn't "hold" but 99% of his posts are on SPL, including a remarkable 350 in the last two months alone. Add SPL (ASX) to my watchlist (20min delay). . . 8985. 54pm 20/11/2023 ? HotCopper has news, discussion, prices and market data on BETMAKERS TECHNOLOGY GROUP LTD. 13. Firstly, I’m a big fan of SPL and proud of all of their achievements to date (even picked up a few more shares the other day). Build your trading strategy and connect with. Imo, financial things such as deals, sales and. 8¢. 0 Created with. Share Given the current status of Starpharma, I am surprised any of these made it through from 2020 but it appears 121,082 did. And SPL still cannot generate enough revenue to even break even! Expand While the current management may be very astute at carrying out research and developing potentially great drug/drug platforms, they ARE NOT showing any signs of success when it comes to commercialisation of these products . And SPL still cannot generate enough revenue to even break even! Expand While the current management may be very astute at carrying out research and developing potentially great drug/drug platforms, they ARE NOT showing any signs of success when it comes to commercialisation of these products . We know that they haven't been marketed well but i think BigPharma have had an input. m. comImagine what SPL's newflow and updates would look like without Viraleze. My theory is we had a large accumulator that was content buying. 32 , that is a daily rise of over 50% on the market capital at the time it hit that low. Additionally, three of the companies mentioned that have approved and marketed IO. 37. As to finding the bottom, a milestone of sorts was reached today for SPHRY (the ADR on the US market equivalent to 10 SPL shares). 0%. I think this is the start of a trail that may lead somewhere in hopefully SPL offering shareholder clearer explainations and referenced articles / posters etc in announcements being on website and then later being unavaliable is a process across the ASX that has to be stopped. Join the HotCopper ASX share market forum today for free. Enquire Now & Supercharge Your Brand with HotCopper 17 Oct 2023. Created with Sketch. 367026. I've been a SPL shareholder since Nov 2015 when I bought a small parcel at 91c. 5¢. ASX - By Stock. HotCopper has over 250,000 registered members, and more than 200,000 unique visitors every month and a huge 21 million monthly page impressions.